Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute’s innovative drug development initiative-Group 3 pulmonary hypertension

By sjmartinez • July 1, 2022

Nikkho SM, Richter MJ, Shen E, Abman SH, Antoniou K, Chung J, Fernandes P, Hassoun P, Lazarus HM, Olschewski H, Piccari L, Psotka M, Saggar R, Shlobin OA, Stockbridge N, Vitulo P, Vizza CD, Wort SJ, Nathan SD. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension. Pulm Circ. 2022 Jul 1;12(3):e12127. doi: 10.1002/pul2.12127. PMID: 36016668; PMCID: PMC9395696.

Tags: Epidemiology, interstitial lung disease, prognosis, Publications, pulmonary hypertension, Pulmonary, Critical Care & Sleep Medicine, symptom assessment and management

Primary Care Practice Productivity and Efficiency: Qualitative Evaluation of a Novel Clinic-Based Measure

McCleskey SG, Khodyakov D, Nelson KM, Curtis I, Newberry SJ, Tran LD, Fihn SD, Wagner TH, Rubenstein LV. Primary Care Practice Productivity and Efficiency: Qualitative[...]

Impact of a stigma-disrupting addiction medicine core curriculum on internal medicine resident attitudes and preparedness: results from a pilot study

Lawrence D, Marshall KF. Impact of a stigma-disrupting addiction medicine core curriculum on internal medicine resident attitudes and preparedness: results from a pilot study. BMC[...]

Decade Growing in Plain Sight: Detection of an Invasive Melanoma Within a Long-Standing Pigmented Lesion

Freeman M, Gates G, Ahronowitz I. Decade Growing in Plain Sight: Detection of an Invasive Melanoma Within a Long-Standing Pigmented Lesion. Cureus. 2026 Oct 10;18(10):e117734.[...]